ACTIVE

Presscuff

Export PDF
Financial year 2025 · closed on 31/03/2025
Net result
-24,1 k €
-116.3% YoY
Gross margin
-22,5 k €
-106.7% YoY
Equity
156,3 k €
+686.9% YoY

What does Presscuff do?

Presscuff is a Private limited company incorporated in 2023. Its registered office is in Diepenbeek.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0800.361.153
Incorporation
04/04/2023
Legal form
Private limited company
Registered office
Agoralaan Abis
3590 Diepenbeek · FlandreSee on map
Contributed capital
191 500,00 €
Latest accounts
31/03/2025
Contacts
2 public details availableLog in to view
Signals
Solid equityLow riskGood liquidity
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 2 financial years

20252024
Income statement
Gross margin-22,5 k €-10,9 k €
EBITDA-23,6 k €-10,9 k €
Operating result-24 k €-11,1 k €
Net result-24,1 k €-11,1 k €
Balance sheet
Equity156,3 k €19,9 k €
Total assets169,3 k €30,1 k €
Cash152,4 k €21,2 k €
Debts13 k €10,3 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/03/2025 · 3 active · 2 ended

Active mandates

MABECO

Director · since 13 novembre 2024 · 1001.440.866

Represented by Benjamin De Vlam

Active
SureFinance

Director · since 13 novembre 2024 · 0785.647.738

Represented by Evert Van Meeuwen

Active
Emiel Suijs

Director · since 04 avril 2023

Active

Ended mandates

Emiel SUIJS

Director

Ended
Evert VAN MEEUWEN

Director

Ended
At this address

Other companies at this address

CompanyCBE no.
Bedal International● Active
0841.685.826
BIOCLUE● Active
0719.914.105
BIOKEY● Active
0719.913.808
BIOSTRAND● Active
0719.913.907
Clinitude● Active
0478.640.857
C-Path● Active
0762.683.482
FOx Biosystems● Bankrupt
0653.744.366
Highstar Engineering● Active
0685.983.703
IDEA FAMILY● Active
0719.674.177
NanoBiotech● Active
1023.651.490
Reprosci Biosciences● Active
1008.398.241
Sealantium Medical Belgium● Active
1012.599.727
SIMABS● Active
0732.709.096
Stichting Administratiekantoor Bedal International● Active
1011.224.604
StingOrg● Active
0804.587.383
Annual accounts

Full financial information

20252024
Type of accountMicro modelMicro model
Start of the financial year01/04/202431/03/2023
Closing of the financial year31/03/202531/03/2024
Length of the financial year12 months13 months
Filing date31/10/202530/10/2024
General meeting30/09/202530/09/2024
Currency of the financial yearEUREUR
NBB quality labelSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

2 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/03/202530/09/202531/10/2025DutchPDF
Micro model31/03/202430/09/202430/10/2024DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/03/2025 · 3 active · 2 ended

Active mandates

MABECO

Director · since 13 novembre 2024 · 1001.440.866

Represented by Benjamin De Vlam

Active
SureFinance

Director · since 13 novembre 2024 · 0785.647.738

Represented by Evert Van Meeuwen

Active
Emiel Suijs

Director · since 04 avril 2023

Active

Ended mandates

Emiel SUIJS

Director

Ended
Evert VAN MEEUWEN

Director

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Capital / shares12/01/2026
    KAPITAAL - AANDELEN
    PDF
  • Mandates14/03/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares09/01/2025
    KAPITAAL - AANDELEN
    PDF
  • Other06/04/2023
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-24,1 k €↓
  2. 2024
    Annual accounts 2024-11,1 k €
  3. 04/04/2023
    IncorporationPrivate limited company